As we move forward into 2024, the pharmaceutical, biotechnology, and medical device industries continue to witness unparalleled growth, much of which is propelled by the groundbreaking work of Contract Research Organizations (CROs). These entities are not merely facilitators of clinical trials…
Simon Corman Joins FOMAT to Help Innovate Healthcare Through Diversity
Simon Corman has over 20 years of experience as a cutting-edge leader in clinical research. His strengths revolve around corporate and business development- with an ability to create strategic partnerships with various CROs and Sponsors and form public-private partnerships that support…
Good Clinical Practice
Abstract Good Clinical Practice (GCP) is an international ethical and scientific quality standard for the design, conduct, performance, monitoring, auditing, recording, analyses and reporting of clinical trials. It also serves to protect the rights, integrity, and confidentiality of trial subjects. It…
Top Clinical Research Organizations at a Glance!
Clinical Research would be a lot more difficult without the help of Clinical Research Organizations (CROs). These companies within the pharmaceutical industry not only help support drug companies but also companies in the biotechnology and medical device industries as well. Some…
FOMAT AT DIA 2017
GAMES, PANAMA HATS, COFFEE, CHOCOLATE & CLINICAL RESEARCH DIVERSITY AT DIA 2017 From June 19th to the 21st FOMAT Medical Research hosted booth #958 at the DIA Meeting 2017 in Chicago, IL. FOMAT Medical Research is always looking for ways to…
Inside FOMAT: Clinical Research Coordinator at FOMAT Involved in Important Research
Carla Geovanna Rodríguez Proaño is an Ecuadorian Biotechnology Engineer, who also obtained a master’s degree in Forensic Science, from King’s College in London. She has been conducting clinical research with FOMAT Medical Research since last year and was recently involved in…
Colombian Pharmaceutical Market to See Strong Four Year Growth
The pharmaceutical market in Colombia is set to rise from $5 billion in 2015 to $7.1 billion by 2020, registering a compound annual growth rate (CAGR) of 7.3%, according to research and consulting firm GlobalData. The company’s latest report states that this substantial…
Phase II-III Services- South America
FOMAT Medical is a specialist in Phase 2, 3 & Phase 4 clinical trials in South America. FOMAT is a Site Management Organization providing services that specialize in the development and management of clinical trials. We meet expectations by concentrating on…
Microcapsule Eliminates Toxic Punch of Experimental Anti-Cancer Drug
Johns Hopkins researchers have developed a sugar-based molecular microcapsule that eliminates the toxicity of an anticancer agent developed a decade ago at Johns Hopkins, called 3-bromopyruvate, or 3BrPA, in studies of mice with implants of human pancreatic cancer tissue. The encapsulated…